Axiata Group Berhad
Axiata Group Berhad (AXXTF) Financial Performance & Income Statement Overview
Analyze Axiata Group Berhad (AXXTF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Axiata Group Berhad (AXXTF) Income Statement & Financial Overview
Explore comprehensive income reports for Axiata Group Berhad AXXTF, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.36B | $5.32B | $5.76B | $5.66B |
| Cost of Revenue | $417.86M | $421.03M | $531.24M | $4.39B |
| Gross Profit | $4.94B | $4.90B | $5.22B | $1.27B |
| Gross Profit Ratio | $0.92 | $0.92 | $0.91 | $0.23 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $327.04M | $342.55M | $436.28M | $454.34M |
| Operating Expenses | $3.90B | $4.90B | $5.22B | $451.88M |
| Total Costs & Expenses | $4.31B | $5.32B | $4.81B | $4.84B |
| Interest Income | $65.56M | $55.01M | $41.63M | $57.94M |
| Interest Expense | $571.64M | $562.22M | $602.97M | $602.03M |
| Depreciation & Amortization | $1.75B | $1.82B | $1.88B | $1.92B |
| EBITDA | $2.45B | $3.81B | $2.93B | $2.71B |
| EBITDA Ratio | $0.46 | $0.72 | $0.51 | $0.48 |
| Operating Income | $1.05B | $0.00 | $971.78M | $822.51M |
| Operating Income Ratio | $0.20 | $0.00 | $0.17 | $0.15 |
| Other Income/Expenses (Net) | -$854.47M | $1.43B | -$521.00M | -$626.65M |
| Income Before Tax | $193.83M | $1.43B | $450.78M | $195.87M |
| Income Before Tax Ratio | $0.04 | $0.27 | $0.08 | $0.03 |
| Income Tax Expense | $240.51M | $289.50M | $249.26M | $167.26M |
| Net Income | -$224.77M | $976.66M | $134.90M | $60.03M |
| Net Income Ratio | -$0.04 | $0.18 | $0.02 | $0.01 |
| EPS | -$0.02 | $0.11 | $0.01 | $0.006 |
| Diluted EPS | -$0.02 | $0.11 | $0.01 | $0.006 |
| Weighted Avg Shares Outstanding | $9.18B | $9.18B | $9.18B | $9.18B |
| Weighted Avg Shares Outstanding (Diluted) | $9.19B | $9.20B | $9.20B | $9.19B |
The company's financials show resilient growth, with revenue advancing from $5.66B in Q1 2024 to $5.36B in Q4 2024. Gross profit remained healthy with margins at 92% in Q4 2024 compared to 23% in Q1 2024. Operating income hit $1.05B last quarter, sustaining a consistent 20% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $2.45B. Net income dropped to -$224.77M, while earnings per share reached -$0.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan